Peter Ogram

Peter Ogram serves as the EVP of Global Business Development at Tanner Pharma Group since April 2024, following a significant tenure at Jazz Pharmaceuticals from January 2014 to December 2022, where notable achievements included the development of the Global Value Lead role and overseeing International Portfolio Strategy. Earlier roles at Gentium GmbH involved directing the marketing and launch of DEFITELIO, while experience at Amgen GmbH included managing international business development and strategic planning initiatives. Peter Ogram holds an MBA from Saïd Business School, University of Oxford, and a BA in Economics from William & Mary.